Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Pazopanib

2 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    COGADVL1322

    10/31/2016

    A Phase II Study of Pazopanib (GW786034, NSC# 737754) in Children, Adolescents and Young Adults with Refractory Solid Tumors

    Treatment

    VICCGI1250

    04/09/2013

    A Phase I/II Study of the Combination of Temozolomide and Pazopanib in Advanced Pancreatic Neuroendocrine Tumors (PNET)


    Print this page for your doctor